NFGH
RXRX icon

Nan Fung Group Holdings’s Recursion Pharmaceuticals RXRX Stock Holding History

Nan Fung Group Holdings’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.83M Hold
595,287
– – 1.51% 17
2025
Q4 		$2.43M Hold
595,287
– – 2.18% 13
2025
Q3 		$2.91M Sell
595,287
-69,323
-10% -$364K 4.87% 8
2025
Q2 		$3.36M Hold
664,610
– – 5.3% 7
2025
Q1 		$3.52M Hold
664,610
– – 2.87% 15
2024
Q4 		$4.49M Buy
+664,610
New +$4.47M 3.84% 10

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Nan Fung Group Holdings's RXRX Position: Q1 2026 in Review

Nan Fung Group Holdings held its Recursion Pharmaceuticals (RXRX) position steady in Q1 2026 at 595,287 shares worth $1.83M. The position accounts for 1.51% of the portfolio, ranked #17.

Nan Fung Group Holdings first reported a position in RXRX in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.49M in Q4 2024. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • Nan Fung Group Holdings held 595,287 shares of Recursion Pharmaceuticals worth $1.83M as of Q1 2026.
  • Nan Fung Group Holdings left its Recursion Pharmaceuticals share count unchanged in Q1 2026.
  • Recursion Pharmaceuticals made up 1.51% of Nan Fung Group Holdings's portfolio in Q1 2026, its #17 holding.
  • Nan Fung Group Holdings first reported a position in Recursion Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Nan Fung Group Holdings's Recursion Pharmaceuticals position peaked at $4.49M in Q4 2024.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Nan Fung Group Holdings's 13F filing for Q1 2026, filed 14 May 2026.